Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
U.K.-based Lucida Medical’s diagnostic tool is already deployed by the NHS, with the company earmarking the funds for the pursuit of regulatory approval in the U.S.
The new agentic program, called “Avery,” is now available to millions of UnitedHealthcare members through its existing app. The insurer said the model will help patients to find providers, understand benefits, get updates on claims and more.
Patients with coronary artery disease and severe aortic stenosis often undergo PCI before TAVR. According to new data presented at ACC.26, however, deferring PCI is associated with comparable outcomes as well as a reduced bleeding risk.
New findings from a large CT lung cancer screening dataset reveal that a substantial number of patients have significant incidental findings visible on their scans.
Lines included in the kits were misassembled and could result in a botched blood transfusion. Due to the risk of serious injury or death, the recall has been designated as Class I.
Endotracheal tubes inside Medline neonatal intubation kits have been deemed too narrow, putting newborn patients at risk for hypoxia. This recall has been given the most serious FDA designation due to the risk of death.
Law firm Wright & Schulte said they filed a legal complaint on behalf of patients, pointing to the health system’s alleged lack of transparency and negligence in protecting data as the basis for the lawsuit.
Janet Wei, MD, examined the key differences between men and women when it comes to cardiovascular disease. These differences, she said, highlight why female patients need their very own treatment guidelines.
Lawmakers led by Rep. Greg Murphy, MD, R-N.C., are reintroducing the Provider Reimbursement Stability Act of 2026, which is endorsed by the AMA and MGMA.
